glp 1 and bipolar disorder Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports The Emotional Rollercoaster: Bipolar Disorder

The Lantus SoloSTAR pen is gray with a purple injection button

Modern GLP-1 receptor agonists have demonstrated average weight loss of 15-20% of body weight with sustained treatment, representing a breakthrough in obesity pharmacotherapy that approaches the effectiveness of bariatric surgery

GLP-1 stands for glucagon-like peptide-1, which is a natural hormone released in our body after eating

There have been some studies suggesting that GLP-1 medications reduce symptoms of schizophrenia in animals

Pharmacokinetic and anti-drug antibody (ADA) assessments are vital for optimizing dosing and safety of GLP-1 receptor agonists

Gopal, P